Concepedia

Sally Kilbride

SK

16

Publications

2.1K

Citations

14

H-Index

2013

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Cornell University

Johns Hopkins Medicine

Sally Kilbride is an author at Research Triangle Park Foundation specializing in medicine, pulmonary disease, and pulmonary medicine.

ORCID

Top concepts

Publications per year

2013–2021

16

Publications

16

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 237 citations · Full text

Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD

Bartolomé R. Celli, Glenn Crater, Sally Kilbride et al. · CHEST Journal · 2014 · 155 citations

, , +5

Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: A randomised trial

Fernando J. Martínez, Joseph Boscia, Gregory Feldman et al. · Respiratory Medicine · 2013 · 139 citations · Full text

Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials

James F. Donohue, Dave Singh, Clara Munzu et al. · Respiratory Medicine · 2016 · 64 citations · Full text

Rows per page

1–5 of 16